Access to effective addiction treatment can sometimes be hindered by financial constraints
This is where the Brixadi Copay Assistance Program comes into play. It’s designed to make the addiction medication Brixadi more affordable and accessible to individuals struggling with opioid use disorder.
Read on to learn how Brixadi Copay Assistance works and how you can qualify for it .
Brixadi Copay Assistance, Explained
The Brixadi Copay Assistance or Brixadi Copay Savings Program aims to reduce the financial burden of acquiring medication-assisted treatment for eligible patients.
If you have commercial insurance, you may qualify for Brixadi Copay Assistance where you can receive Brixadi at no cost ($0 copay). The copay savings reset at the beginning of each calendar year, meaning you can continue to benefit from this program year after year if you’re eligible.
The eligibility criteria for the Brixadi Copay Savings Program are as follows:
- Commercially Insured Patients: You need to have commercial insurance coverage to be eligible for the program. Unfortunately, patients with state or federally-funded insurance (Medicaid, Medicare, TRICARE, Veteran Affairs health care, etc.) aren’t eligible.
- Plan Coverage: Patients on insurance plans that don’t cover Brixadi are also not eligible for copay savings.
Enrolling in the Brixadi Copay Savings Program
To enroll in the Brixadi Copay Savings Program, follow these steps:
- Sign Up: Visit the Brixadi website and obtain your unique copay ID number. This number is essential for the enrollment process.
- Provide Your ID to Your Doctor: Share your copay ID number with your healthcare provider. They’ll need it to coordinate with the specialty pharmacy.
- Specialty Pharmacy Application: If approved, the specialty pharmacy will apply the copay savings directly to your out-of-pocket costs for Brixadi.
Bear in mind that you may need the following information to enroll in the program:
- Full name of your healthcare provider
- Healthcare provider’s address
- City, state, and zip code
- Fax number
More About Brixadi
Brixadi is a long-acting injectable form of buprenorphine, designed to help individuals struggling with moderate to severe opioid use disorder manage their cravings and withdrawal symptoms. It’s administered weekly (7-day intervals) or monthly (28-day intervals), making it a convenient and discreet choice for people in recovery.
Brixadi contains buprenorphine, which is a partial opioid agonist. Here’s how it works:
- Craving Reduction: Buprenorphine binds to the opioid receptors in your brain, and so it reduces cravings for stronger opioids like fentanyl and heroin.
- Withdrawal Symptoms Management: By partially activating your opioid receptors, buprenorphine eases withdrawal symptoms without causing the intense euphoria associated with full agonists like methadone.
- Stabilization: Brixadi has proven to be an effective stabilizer, allowing you to focus on recovery without the constant struggle of cravings.
The extended-release medication is often recommended to patients who have either started treatment with a single dose of a transmucosal buprenorphine product (sublingual tablets or buccal films) or are already receiving buprenorphine therapy.
Note: Brixadi is injected into the upper arm, abdomen, or thighs. Injection sites should be rotated to prevent discomfort.
How Brixadi Differs From Other Treatments
When considering a complete treatment plan for severe OUD, it’s important to understand how Brixadi differs from other commonly used treatments.
Brixadi vs. Oral Medications (e.g. Suboxone):
- Frequency: Unlike daily oral medications, Brixadi is administered as a weekly or monthly injection. This reduces the need for daily dosing and ensures consistent medication levels.
- Discretion: You can receive Brixadi discreetly without drawing attention to your treatment.
- Convenience: Brixadi’s injectable form eliminates the need to remember daily pills, making it a more convenient choice for individuals in recovery.
Brixadi vs. Methadone:
- Administration Setting: Methadone is often administered in specialized clinics, whereas Brixadi injections can be administered in various healthcare settings.
- Withdrawal Management: Brixadi helps manage withdrawal symptoms more effectively than methadone. It promotes stability during recovery.
- Risk of Overdose: Methadone carries a higher risk of overdose due to its full opioid agonist properties. Per contra, Brixadi comes with a lower overdose risk since it’s a partial agonist.
Note: Treatment for OUD requires continuing care, which includes counseling, not just medication.
Frequently Asked Questions
How Much Does Brixadi Cost?
At no copay, the cost of a 0.16-milliliter supply of Brixadi subcutaneous solution (8mg/0.16mL) is around $459. The price will likely vary based on your insurance plan, location, and where you receive your Brixadi injections.
Is Buvidal the Same as Brixadi?
Brixadi is the U.S. trademark for Camurus’ Buvidal, available in the EU, UK, New Zealand, Australia, Switzerland, and several other countries in North Africa and the Middle East. The rights to Brixadi in North America are licensed to Braeburn by Camurus.
Medication-Assisted Addiction Treatment Can Help You…
Brixadi Copay Assistance is a program that aims to bridge the gap between affordability, accessibility, and effective opioid addiction treatment.
If you have commercial insurance—not state or federally funded—and your insurance plan covers Brixadi, you can enroll in the program to receive Brixadi at $0 copay. All you need to do is visit Brixdai’s website, sign up, and obtain your unique copay ID number.
Do you have an inquiry or need help on your recovery journey? You can reach out to Curednation at any time.
